A Single-center, Open-label, Randomized, Double-crossover, Propofol-controlled, Two-stage Study Evaluating the Safety and Pharmacokinetics/Pharmacodynamics of IV Maintenance Dose and IV Single Loade Dose Plus Maintenance Dose of HSK3486 Emulsion fo Injection in Healthy Subjects
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 29 Jan 2019
At a glance
- Drugs HSK 3486 (Primary) ; Propofol
- Indications Anaesthesia; Sedation
- Focus Adverse reactions
- Sponsors Sichuan Haisco Pharmaceutical
- 18 Jan 2019 Planned End Date changed from 1 Jul 2019 to 1 Apr 2019.
- 18 Jan 2019 Planned primary completion date changed from 1 Jan 2019 to 28 Feb 2019.
- 18 Dec 2018 Planned initiation date changed from 30 Nov 2018 to 30 Dec 2018.